Skip to the page

Data / Form D filings / Ocean Biomedical, Inc.

Ocean Biomedical, Inc.: Form D filing

Ocean Biomedical, Inc., a biotechnology company in Providence, RI, filed a Form D with the SEC in 2023. The latest, on June 15, 2023, reports $7.6 million sold of a $27 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
55 CLAVERICK STREET, ROOM 325, Providence, RI, 02903
Phone
(401) 444-7375
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1869974

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 15, 2023New notice$27,000,000$7,560,000$19,440,0001May 25, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jack A. EliasDirector
William A. OwensDirector
Jonathan A. KurtisDirector
Michael A. PetersonDirector
Robert SweeneyExecutive Officer
Martin D. AngleDirector
Inderjote KathuriaExecutive Officer
Michelle D. BerreyDirector
Gurinder KalraExecutive Officer
Jerome A. RingoDirector
Daniel BehrExecutive Officer
Suren A. AjjarapuDirector
Elizabeth NgExecutive Officer, Director
Chirinjeev KathuriaDirector

Every Form D from the week of Jun 12, 2023 · All recent filings in Rhode Island · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Ocean Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.